The Baruch S. Blumberg Institute presented the 2025 Lam Excellence in Medicinal and Chemistry Award recently to Dan Nguyen, BS, senior research scientist in medicinal chemistry, Blumberg Institute and Mark E. McDonell, PhD, director of chemistry, Fox Chase Therapeutics Discovery.
Mark McDonell has been with FCTDI for over 14 years. Previously Dr. McDonell worked at Johnson & Johnson for 18 years. Currently he serves as a principal investigator on a Phase II SBIR-funded project directed to the discovery of new treatments for Chagas disease.
Dan Nguyen has been with the Blumberg Institute as senior research scientist of medicinal chemistry since 2024. He has extensive experience in the design, multi-step synthesis, purification and characterization of organic molecules for various biological targets. Prior to joining the Institute, he was senior scientist of medicinal chemistry at Arbutus Biopharma.
The Blumberg Institute presents the Lam Excellence in Medicinal and Chemistry Award annually in recognition of Patrick Y. S. Lam, PhD, distinguished professor at the Blumberg Institute. Dr. Lam has established a strong model for medicinal chemists that embodies two essential areas. First, as group leader of discovery of Eliquis, a world top-selling drug that helps to alleviate human suffering. Second, as co-discoverer of the powerful Chan-Lam Coupling Reaction used in synthesizing/manufacturing of biologically active compounds.
The Lam Award was created in 2021 by Yanming Du, PhD, professor and director of medicinal chemistry at the Blumberg Institute.
The Baruch S. Blumberg Institute presented the 2025 Lam Excellence in Medicinal and Chemistry Award recently to Dan Nguyen, BS, senior research scientist in medicinal chemistry, Blumberg Institute and Mark E. McDonell, PhD, director of chemistry, Fox Chase Therapeutics Discovery.
Mark McDonell has been with FCTDI for over 14 years. Previously Dr. McDonell worked at Johnson & Johnson for 18 years. Currently he serves as a principal investigator on a Phase II SBIR-funded project directed to the discovery of new treatments for Chagas disease.
Dan Nguyen has been with the Blumberg Institute as senior research scientist of medicinal chemistry since 2024. He has extensive experience in the design, multi-step synthesis, purification and characterization of organic molecules for various biological targets. Prior to joining the Institute, he was senior scientist of medicinal chemistry at Arbutus Biopharma.
The Blumberg Institute presents the Lam Excellence in Medicinal and Chemistry Award annually in recognition of Patrick Y. S. Lam, PhD, distinguished professor at the Blumberg Institute. Dr. Lam has established a strong model for medicinal chemists that embodies two essential areas. First, as group leader of discovery of Eliquis, a world top-selling drug that helps to alleviate human suffering. Second, as co-discoverer of the powerful Chan-Lam Coupling Reaction used in synthesizing/manufacturing of biologically active compounds.
The Lam Award was created in 2021 by Yanming Du, PhD, professor and director of medicinal chemistry at the Blumberg Institute.